- Zacks•21 hours ago
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks•8 days ago
Let's see if United Therapeutics Corporation (UTHR) stock is a good choice for value-oriented investors right now from multiple angles.
- PR Newswire•9 days ago
How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma
Last Friday, shares in La Jolla, California headquartered Orexigen Therapeutics Inc. ended the session 3.76% lower at $4.10. The stock recorded a trading volume of 182,389 shares. The Company's shares have surged 141.18% in the previous three months and 135.63% on an YTD basis.
UTHR : Summary for United Therapeutics Corporation - Yahoo Finance
United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||158.70 x 500|
|Day's Range||139.68 - 141.82|
|52 Week Range||97.52 - 169.89|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||9.26|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|